Vexatious litigation

Mayfair Gold Files Management Information Circular and Issues Letter to Shareholders

Retrieved on: 
木曜日, 5月 9, 2024

MATHESON, Ontario, May 09, 2024 (GLOBE NEWSWIRE) -- Mayfair Gold Corp. (“Mayfair” or the “Company”) (TSX-V: MFG; OTCQB: MFGCF) today announced that it has filed its management information circular (the “Information Circular”) and related proxy materials in connection with its upcoming Annual General and Special Meeting of Shareholders to be held on June 5, 2024 (the “Meeting”). The Information Circular includes a Letter to Shareholders from Harry Pokrandt, Chairman of the Company’s board of directors (the “Board”). The Company also announced it has entered into a Settlement Agreement (as defined below) with certain employees of the Company to ensure the retention of their services on behalf of Mayfair up to the Meeting.

Key Points: 
  • The Information Circular includes a Letter to Shareholders from Harry Pokrandt, Chairman of the Company’s board of directors (the “Board”).
  • The Board unanimously recommends that shareholders vote to RE-ELECT as directors each of Harry Pokrandt, Patrick Evans, Christopher Reynolds and Douglas Cater (the “Company Nominees”).
  • Over the past year, the Company is among the top-performing gold stocks among Canadian gold mining exploration and development companies.
  • The Company’s share price has outperformed the 17% increase in the price of gold during the same time period.

Perma-Fix Reports Financial Results and Provides Business Update for the First Quarter of 2024

Retrieved on: 
木曜日, 5月 9, 2024

ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today announced financial results and provided a business update for the first quarter ended March 31, 2024.

Key Points: 
  • ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today announced financial results and provided a business update for the first quarter ended March 31, 2024.
  • Mark Duff, President and CEO of the Company, commented, “As previously disclosed, our financial performance in the first quarter of 2024 was impacted by a few temporary headwinds.
  • However, we have seen steady improvement heading into the second quarter and anticipate a strong second half of 2024.
  • Revenue was $13.6 million for the first quarter of 2024 as compared to $20.1 million for the corresponding period of 2023.

Ancora Issues Letter to Norfolk Southern’s Board to Refute False and Unsupported Claims, Including Those Regarding Railway Labor Act Violations and “Vote Buying” from Labor

Retrieved on: 
月曜日, 5月 6, 2024

It’s been inaccurate when Norfolk Southern has suggested in recent days that it has the full support of rail unions.

Key Points: 
  • It’s been inaccurate when Norfolk Southern has suggested in recent days that it has the full support of rail unions.
  • It is equally important to note that many, if not most, of the BLET and the BMWED members at Norfolk Southern are both employees and shareholders.
  • These claims overlook key facts, including the following:
    The parties are completely confident that they are in compliance with applicable law, including the Railway Labor Act.
  • Norfolk Southern’s own counsel wrote to Ancora and acknowledged that memoranda among the parties were not binding on the Company.

Sling Pilot Academy and the City of Torrance Settle Business License Dispute

Retrieved on: 
日曜日, 4月 28, 2024

TORRANCE, Calif., April 28, 2024 /PRNewswire/ -- Sling Pilot Academy , a premier flight training institution located in Torrance, CA, and the City of Torrance have settled a dispute in State Court over Sling's business license.

Key Points: 
  • TORRANCE, Calif., April 28, 2024 /PRNewswire/ -- Sling Pilot Academy , a premier flight training institution located in Torrance, CA, and the City of Torrance have settled a dispute in State Court over Sling's business license.
  • In October 2023 Sling received a letter from the City of Torrance saying that Sling's business license would not be renewed in 2024 due to a never-enforced 1977 resolution limiting the number of flight schools at Torrance Airport.
  • The day before, the City of Torrance City Council voted to enact an Ordinance and Urgency Ordinance limiting the number of flight schools at Torrance Airport to 6 flight schools.
  • Sling Pilot Academy remains committed to working with the City of Torrance and the residents surrounding the airport.

The Chemours Company Reports First Quarter 2024 Results

Retrieved on: 
火曜日, 4月 30, 2024

First quarter 2024 Net Sales for the Performance Solutions product portfolio were $113 million, down 22% vs. the prior-year quarter.

Key Points: 
  • First quarter 2024 Net Sales for the Performance Solutions product portfolio were $113 million, down 22% vs. the prior-year quarter.
  • First quarter 2024 Net Sales for the Advanced Materials product portfolio were $186 million, down 24% vs. the prior-year quarter.
  • Corporate Expenses were a $55 million offset to Adjusted EBITDA in the first quarter 2024, up $10 million vs. the prior-year quarter.
  • For the second quarter of 2024, the Company expects consolidated Net Sales to increase approximately 15% sequentially, with consolidated Adjusted EBITDA also up approximately 15% compared with first quarter 2024 results.

Biote Announces Definitive Settlement with Founder

Retrieved on: 
月曜日, 4月 29, 2024

biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced it has entered into a definitive settlement agreement (the “Settlement Agreement”) that concludes outstanding litigation with Dr. Gary S. Donovitz (“Donovitz”), founder and stockholder of Biote.

Key Points: 
  • biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced it has entered into a definitive settlement agreement (the “Settlement Agreement”) that concludes outstanding litigation with Dr. Gary S. Donovitz (“Donovitz”), founder and stockholder of Biote.
  • The Settlement Agreement includes a mutual release of all claims relating to litigation between Donovitz and Biote; the termination of the founder advisory agreement by and between Donovitz and BioTE Medical, LLC; two year non-compete and non-solicitation agreements for Donovitz; and a voting agreement with customary terms acceptable to the Company.
  • Additionally, Biote will repurchase all 18.4 million Biote shares beneficially held by Donovitz.
  • Terry Weber, Biote Chief Executive Officer, commented, “We are pleased to conclude this legal matter, which resolves prolonged and costly litigation.

Nanophase Announces Successful Litigation Settlement

Retrieved on: 
木曜日, 4月 11, 2024

The parties have executed a Settlement Agreement, an amendment to their existing supply contract, and a joint stipulation to dismiss the case with prejudice to be filed in the Superior Court of New Jersey within the next five business days.

Key Points: 
  • The parties have executed a Settlement Agreement, an amendment to their existing supply contract, and a joint stipulation to dismiss the case with prejudice to be filed in the Superior Court of New Jersey within the next five business days.
  • “We are happy to conclude this litigation on positive terms.
  • BASF has been a good partner to Nanophase over the years, and we expect that partnership to continue to bear fruit in the future,” said Nanophase President and Chief Executive Officer, Jess Jankowski.
  • Completion of the settlement allows Nanophase and Solésence to focus on what we do best, while continuing to support our sale of mineral-based Active Pharmaceutical Ingredients (“API”), into a market that recognizes the benefits these solutions bring,” continued Jankowski.

Former registrant settles with the ASC for unregistered dealing

Retrieved on: 
月曜日, 4月 15, 2024

He introduced, promoted and discussed the agreements with the investors and provided them with the company's promotional materials, which projected high rates of return.

Key Points: 
  • He introduced, promoted and discussed the agreements with the investors and provided them with the company's promotional materials, which projected high rates of return.
  • The ASC gratefully acknowledges the assistance of the United States Securities and Exchange Commission (SEC) in this matter.
  • The ASC is the regulatory agency responsible for administering the province's securities laws.
  • As a member of the Canadian Securities Administrators, the ASC works to improve, coordinate and harmonize the regulation of Canada's capital markets.

Holley Ordered to Disgorge $2 Million in Ill-Gotten Profits

Retrieved on: 
火曜日, 4月 9, 2024

“Proform”) that started 24 years ago when Holley filed suit against Specialty, alleging that Specialty had misappropriated the “trade dress” of Holley’s carburetor main bodies.

Key Points: 
  • “Proform”) that started 24 years ago when Holley filed suit against Specialty, alleging that Specialty had misappropriated the “trade dress” of Holley’s carburetor main bodies.
  • So in 2012 Specialty filed a summary enforcement motion suit claiming that Holley was failing to comply with the Settlement Agreement.
  • In 2017 Specialty filed its breach of contract lawsuit against Holley for violating the Settlement Agreement, arguing that it was entitled to disgorgement of the $2,028,264.19 in net profit reaped by Holley.
  • Specialty prevailed in this lawsuit, and the court entered summary judgment in favor of Specialty and against Holley.

Scilex Holding Company Announces a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s Filing of a sNDA with the FDA Seeking to Expand the Label for its FDA-Approved Liquid Colchici

Retrieved on: 
水曜日, 3月 20, 2024

That litigation arose from Scilex’s filing of a sNDA with the FDA seeking to expand the label for its FDA-approved liquid colchicine product, Gloperba®, a preventive treatment for gout.

Key Points: 
  • That litigation arose from Scilex’s filing of a sNDA with the FDA seeking to expand the label for its FDA-approved liquid colchicine product, Gloperba®, a preventive treatment for gout.
  • As part of the Settlement Agreement, the Scilex Parties entered into a License Agreement with Takeda granting the Company and its affiliates a non-exclusive license to certain patents owned by Takeda.
  • The Settlement Agreement is subject to approval by the district court, and by both the Federal Trade Commission and the U.S. Department of Justice, as is required in Paragraph IV patent case settlements.
  • For more information on Scilex Holding Company, refer to www.scilexholding.com .